Clinical Trials

Toll-Free: 866.320.4573

Call Us Toll Free:

866.223.2273 x1234

Early Diagnosis of Pulmonary Nodules

Study:

Early Diagnosis of Pulmonary Nodules Using A Plasma Proteomic Classifier, Protocol Number 1001-12

Rationale:

n/a

Purpose:

This study is intended to determine the positive predictive value (PPV) and negative predictive value (NPV) of the multiprotein classifier based on the observed study prevalence of Non-Small Cell Lung Cancer (NSCLC) in the study participants.

Study Status: Recruiting

Recruiting:
Mary Beukemann 216-445-8951 beukemm@ccf.org

Condition Intervention Phase
Precancerous Conditions
Carcinoma
n/a N/A

Verified by Integrated Diagnostics October, 2013

Sponsored by: Integrated Diagnostics
Information provided by: Integrated Diagnostics
ClinicalTrials.gov identifier: NCT01752114

Study Type: Interventional

Study Design: Observational Model: Cohort, Time Perspective: Prospective

Cleveland Clinic
Cleveland, Ohio 44195
United States

Kenneth Fang, MD., Study Director

This information is abridged to display results relevant only to Cleveland Clinic. To see complete record visit ClinicalTrials.gov
  Information obtained from ClinicalTrials.gov on
Link to the current ClinicalTrials.gov record.

Cleveland Clinic Mobile Site